after yesterdays agm statement the share price has risen 50% how much upside is left or is this another false dawn?
http://www.alexa.com/data/details/traffic_details/thewellnessshop.co.uk
womans hour link below.
http://www.bbc.co.uk/radio4/womanshour/04/2008_08_mon.shtml

A very good read take note of paragraph 5

Wednesday, January 23, 2008 - 12:35

Anxiety, Addiction and Depression Treatments
SSRI Maintenance Doesn't Prevent Recurring Depression

Chronically depressed patients who've recently emerged from a particularly low period but continue taking their antidepressant (AD) medications in order to pre-empt a recurrence are actually just as likely to fall back under the disorder's influence, according to new research.

Many individuals suffer from chronic, recurring depression that often moves in a wave-like pattern, with periods of relative stability lasting months or years before the disorder inevitably returns with renewed strength. These "relapses" may be related to personal circumstances but more often simply represent the patients' biological predispositions. Patients are particularly susceptible if their depressive periods last more than three months, if they began before the age of 25, or if the patients have experienced recurrence within two months of discontinuing medications in the past. The most common preventive strategy for depression is the continuation of AD medications - one assumes that, by keeping patients on their medications, the risk of future depressive periods will be downgraded or eliminated due to the constant presence of antidepressant pharmaceutical substances in their systems.

But despite contradictory earlier research concerning AD maintenance among the elderly, a new study implies that certain patients susceptible to mood disorders do not benefit from AD maintenance regimens taken during periods of euthymia (or balanced, non-depressive mood), and that such treatment plans do not significantly decrease the likelihood that they will revert to their previous state. While elderly AD patients reported increased sociability, lifestyle activity and general disposition while on SSRIs as opposed to strict placebo or personal therapy approaches, these trends seem to apply more directly to late-life depression. Another difference between the two studies was the fact that the elderly patients in the later study were notably depressed and not experiencing periods of emotional stability at the time of the study.

The most recent research involved 172 patients who were, at the time of the study, experiencing lulls in their recurrent states of depression. Researchers based the study on a notable trend among AD maintenance patients: many decide independently to stop taking their medications, a move most likely prompted by a sense of renewed strength allowing them to "beat" the disease but certainly not in keeping with their doctors' orders. In fact, a majority of the patients in this study group discontinued their medications, and most of them, of course, reported a return of depressive symptoms during the study's 2 year duration.

5-((But even among the 26% who continued to take their meds exactly as prescribed, a majority (60%) reverted to depressive states before study's end. Patients who took their medications sporadically had only slightly higher rates of recurrence (63%), implying that the preventive power of these SSRI medications is minor at best. In fact, the study's most positive results came for patients undergoing periods of brief cognitive therapy - an approach that has proven effective among patients with chronic conditions not spurred by individual life traumas.))

Therapy to compliment medication is crucial for patients who deal with the problem on a lifelong rather than periodic basis.

This is not to discount the power of antidepressants or dismiss their use entirely - they are essential parts of a successful treatment regimen for millions of affected patients, and those wishing to discontinue their antidepressants due to perceived symptomatic upturns should reconsider and proceed with caution, especially if they've experienced more than one depressive period in recent years. This study simply enumerates the fact that these medications, on their own, do not constitute a one-stop cure, especially when relating to depression that has yet to manifest itself. They seem to lose their efficacy once the body has become accustomed to their presence in much the same way that drinkers build up a greater degree of tolerance to alcohol over time. Victims of recurring depression understandably experience great relief as their symptoms recede, but just as they cannot attribute their recovery to pharmaceuticals alone, they should not take such developments as proof that they no longer need their medications. A combination of meds and therapy has repeatedly proven very effective in clinical trials, and all patients should be aware of this fact before they consider taking the course of their treament into their own hands.

you would be far less depressed were you not invested in ULT!
perhaps that's their USP!?

just highlighting the facts cynic for those who have no need to take money out of company's to play with.
But saying that i do val your opinion. sometime but lets not foget your name Cynic.

perhaps i should change my handle to Bald Truth then!

nar just woulden be you...............;-) stay as you are cynic are good to have around they keep as on our toes..also their a pain in .... .......

This is one case that highlight the dangerou of durgs. the time is here for change

Thursday, January 24, 2008 - 12:19 posted by TheEditorInChief

Anxiety, Addiction and Depression Treatments
Powerful Prescription Drugs May Have Had Role in Celebrity Death

Oscar nominated actor Heath Ledger passed away this past Tuesday in his New York City apartment. At the age of 28, Ledger was a highly regarded screen presence who had appeared in such films as 10 Things I Hate About You, A Knight's Tale, and perhaps most famously Brokeback Mountain, for which Ledger received his Oscar nod. While many of the details of his passing remain unclear, what is agreed upon is that Ledger was discovered unconscious in his bedroom on the afternoon in question and could not be revived despite the best efforts of emergency response personnel. Approximately 30 minutes elapsed between the time that a masseuse discovered Ledger's unresponsive form and the time that police were called; he was pronounced dead shortly after authorities arrived.

A search of the apartment in the wake of this tragedy uncovered no illegal drugs, but revealed that Ledger had several powerful prescription drugs in his apartment. While most mainstream news outlets have reported that there were six different prescriptions, and that some were anti-anxiety medications and sleeping aides, most outlets have demurred at specifically naming the substances. Other, more celebrity focused outlets, have reported that these scripts were for Ambien, Xanax, and Valium. Results of an autopsy were inconclusive on Wednesday, and examiners say that it will be at least a week before anything further is known.

We do not want to engage in idle speculation, but there are several questions that should be kept in mind as more information becomes available: what role did these psychoactive compounds play in Mr. Ledger's untimely passing? How did an otherwise healthy 28-year-old obtain prescriptions for these medications, and for what conditions were they prescribed? Perhaps most importantly, where is the physician who gave Mr. Ledger access to this dangerous cocktail of powerful drugs?

Unfortunately, no set of answers will bring back this talented individual, but in the public mourning that surrounds his death, we all might benefit from taking stock of these and other questions. Drugs like Xanax, Valium, and Ambien�not to mention whatever other prescriptions are eventually revealed to have had a role in this incident�should never be used in any way that has not been approved by a physician for a specific purpose. It may be revealed that Mr. Ledger's death was completely accidental and that the possession of so many prescription medications was only a coincidence. But the presence of those drugs in combination does belie a cavalier attitude about pharmaceuticals that permeates much of our society. And Mr. Legder's death could very well come to serve as a reminder of the ultimate tragedy that can be born of such dangerously negligent behaviors.

here's a surprise .... FTSE continues its significant recovery and ULT stays dead in the gutter

It'll be some time before the sp will rise Cynic, it has risen on potential in the past, then fallen on disappointment but I think it is a little more stable these days and far more representative of where this company now is. An upbeat statement from the Chairman in the latest results, as you would expect, but having had a quick run through them, and in light of the government's keenness to push Beating the Blues, I think there is a future for ULT.
Results for the year to 31st July 2007

Consolidated turnover of 1,577,000 shows a 27%
increase on 2006 (1,243,000). It should be noted that turnover in the second half was 52% ahead of last year with first half growth of only 4% as a result of theNHS withholding expenditure pending the completion of the National Framework Agreement for Beating the Blues. Deferred income at the balance sheet date stands at 1,388,000, which includes some recent sizeable contract wins not yet reflected in turnover or operating profit. In accordance with FRS 20 the Group has incurred a non
cash charge of 495,000 in respect of options granted. (2006 as restated: 175,000).Other administrative expenses increased by 29%, mostly through recruitment of additional personnel needed to deliver Beating the Blues in the NHS. This has resulted in an operating loss of 269,000 before share-based payments and 764,000 after share-based payments (2006: 188,000 and as restated 363,000 respectively). The Group remains debt free with cash balances of 879,000 at 31 July 2007

Statement from Chairman and Chief Executive

This year has been defined by the announcement of the then Secretary of State, The Rt Hon Patricia Hewitt MP, that Beating the Blues should be available from April 2007 to all patients with mild to moderate depression, via their GP. It has become clear that funding for this had not been set aside resulting in the majority of PCTs struggling o meet the commitment and a slow uptake. We were therefore delighted when the Prime Minister
confirmed in his Comprehensive Spending Review that extra funding would be directed to PCTs for treating depression and anxiety. This was swiftly supported with
the announcement by Alan Johnson of an additional 170m funding over the next three years for the Improving Access to Psychological Therapies (IAPT) programme. We expect this to now result in the full implementation of Beating the Blues across the NHS as directed by NICE.
Beyond this we are delighted to report our moves into new markets for our products and that continued sales successes have produced a strong cash balance, with no
borrowings, and a sales pipeline making us financially secure and self financing.

I would recommend that you take a look at the results at:-
http://www.ultrasis.com/downloads/Annual%20Report%20and%20Accounts%20for%20the%20year%20ending%2031%20July%202007.pdf

cynic what happened there ftse ends down ult ends up lol

surely 0.01p is no more than a dead man's twitch!?

could be the rise of the living dead.

Hi all just got back did i miss something today or as ULT realised Results for the year to 31st July 2007 it doesn't look bad ,

Beyond this we are delighted to report our moves into new markets for our products and that continued sales successes have produced a strong cash balance, with no
borrowings, and a sales pipeline making us financially secure and self financing.

includes some recent sizeable contract wins not yet reflected in turnover or operating profit

Any chance they might make a profit sometime soon,not with their overheads methinks? This company is being run for the benefit of the directors and management not for the benefit of shareholders.

halifax profit should be next results how much depends on what you say overheads.

This comes from their.
Results for the year to 31st July 2007

The performance of the Group during the year assessed
according to these indicators was:


2007 2006
Annual Sales Growth 27% 47%
Other operating expenses 116% 114%

as a % of turnover
Revenue generated
per member of staff 113,000 104,000

For those of you that are interested in this share

Making sense of cognitive behaviour therapy ......paste & copy..below

http://www.mind.org.uk/Information/Booklets/Making+sense/MakingsenseCBT.htm

BABCP appoints first-ever Patrons

A SENIOR Appeal Court judge and his wife has been appointed as the BABCPs first-ever Patrons.

Sir Mark and Lady Rachel Waller set up the Charlie Waller Trust in their sons name when he committed suicide after suffering from depression. The couple have funded the first ever Chair of CBT in Britain and created a web site specifically for students suffering from depression.

They were honoured and delighted

to accept being nominated as Patrons following a meeting of the BABCP Board.

Sir Mark and Lady Rachel have worked tirelessly since their son Charlies death ten years ago to raise greater public awareness of depression and the value of CBT as a treatment.

As well as creating their own charity, the Charlie Waller Trust, they have also begun a national programme of employing staff to raise awareness amongst GPs and nurses, created a web site about depression amongst students and supported Lord Layards crusade to make CBT more accessible.

BABCP President David Veale said: They have done a huge amount in a very practical way to reduce the stigma which still surrounds depression, to make more people aware of CBT therapy and to provide real help to other young people.

They are extremely committed and active and will be very effective champions for CBT I am very proud that they have agreed to be the first ever Patrons of the BABCP, as the leading organisation for CBT in the UK.

Sir Mark one of Britains most senior judges said: Its ten years now since Charlie died, but our main thought ever since has always been to do all that we can to make sure that there are fewer young people like him who will suffer from depression.

And to make sure that there are fewer families who have to go through what we went through. It helps us to know that we are doing something useful.

The Charlie Waller Trust (http://www.cwmt.org/index.html) has contributed 250,000 for the first chair in CBT at Reading, held by BABCP member Professor Roz Shafran.

The web site for students - Students Against Depression - is at (http://www.studentdepression.org/site/)

Sir Mark and Lady Rachel have also welcomed the Governments recent announcement of 170million to improve access to psychological therapies like CBT.

Sir Mark said: CBT has unquestionable relevance as a psychological therapy for conditions such as depression, because its efficacy can be tested. It is evidence-based.

We are delighted to give our support to the BABCP in any way that we can.

A fuller version of this article is available in the latest edition of CBT Today, which also includes news about awards for two young researchers.

http://www.telegraph.co.uk/news/main.jhtml;jsessionid=QE2SRNFAI0AHFQFIQMFCFFWAVCBQYIV0?xml=/news/2008/02/02/nbenefit102.xml


Recent figures showed that more than 500,000 people under 35 claim incapacity benefit with tens of thousands of people claiming for conditions such as depression, anxiety, and obesity

A bit of news with this would be nice

its got to be soon agm later this month